FDA Expands Rimegepant Indication to Include Migraine Prevention ...Middle East

Medscape - News
The US Food and Drug Administration has expanded the indication for rimegepant (Nurtec ODT, Biohaven) to include prevention of migraine in adults. FDA Approvals

Hence then, the article about fda expands rimegepant indication to include migraine prevention was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Expands Rimegepant Indication to Include Migraine Prevention )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News